These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9582365)

  • 1. Sequence requirements for association of protein-tyrosine phosphatase PEP with the Src homology 3 domain of inhibitory tyrosine protein kinase p50(csk).
    Gregorieff A; Cloutier JF; Veillette A
    J Biol Chem; 1998 May; 273(21):13217-22. PubMed ID: 9582365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells.
    Davidson D; Cloutier JF; Gregorieff A; Veillette A
    J Biol Chem; 1997 Sep; 272(37):23455-62. PubMed ID: 9287362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel, specific interaction involving the Csk SH3 domain and its natural ligand.
    Ghose R; Shekhtman A; Goger MJ; Ji H; Cowburn D
    Nat Struct Biol; 2001 Nov; 8(11):998-1004. PubMed ID: 11685249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase.
    Cloutier JF; Veillette A
    J Exp Med; 1999 Jan; 189(1):111-21. PubMed ID: 9874568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells.
    Cloutier JF; Veillette A
    EMBO J; 1996 Sep; 15(18):4909-18. PubMed ID: 8890164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
    Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
    J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tyrosine kinase Csk dimerizes through Its SH3 domain.
    Levinson NM; Visperas PR; Kuriyan J
    PLoS One; 2009 Nov; 4(11):e7683. PubMed ID: 19888460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Src homology 3 domain association with the proline-rich domain of dynamins: specificity, occlusion, and the effects of phosphorylation.
    Solomaha E; Szeto FL; Yousef MA; Palfrey HC
    J Biol Chem; 2005 Jun; 280(24):23147-56. PubMed ID: 15834155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of mouse PECAM-1 tyrosine phosphorylation by the Src and Csk families of protein-tyrosine kinases.
    Cao MY; Huber M; Beauchemin N; Famiglietti J; Albelda SM; Veillette A
    J Biol Chem; 1998 Jun; 273(25):15765-72. PubMed ID: 9624175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH3-domain mutations selectively disrupt Csk homodimerization or PTPN22 binding.
    Brian BF; Sjaastad FV; Freedman TS
    Sci Rep; 2022 Apr; 12(1):5875. PubMed ID: 35393453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why the first self-binding peptide of human
    Zhou P; Yan F; Miao Q; Chen Z; Wang H
    J Biomol Struct Dyn; 2021 Jan; 39(1):310-318. PubMed ID: 31872783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk).
    Lee S; Ayrapetov MK; Kemble DJ; Parang K; Sun G
    J Biol Chem; 2006 Mar; 281(12):8183-9. PubMed ID: 16439366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase.
    Tsutsumi R; Higashi H; Higuchi M; Okada M; Hatakeyama M
    J Biol Chem; 2003 Feb; 278(6):3664-70. PubMed ID: 12446738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
    Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
    J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of N-terminal lobe motifs that determine the kinase activity of the catalytic domains and regulatory strategies of Src and Csk protein tyrosine kinases.
    Huang K; Wang YH; Brown A; Sun G
    J Mol Biol; 2009 Mar; 386(4):1066-77. PubMed ID: 19244618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes.
    Cloutier JF; Chow LM; Veillette A
    Mol Cell Biol; 1995 Nov; 15(11):5937-44. PubMed ID: 7565746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase.
    Lee S; Lin X; Nam NH; Parang K; Sun G
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14707-12. PubMed ID: 14657361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5).
    O'Connell JC; McCallum JF; McPhee I; Wakefield J; Houslay ES; Wishart W; Bolger G; Frame M; Houslay MD
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):255-61. PubMed ID: 8761480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.